Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom

[1] Liu YC(2020)COVID-19: the first documented coronavirus pandemic in history Biom J 43 328-333

[2] Kuo RL(2020)COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain Kidney Int 98 27-34

[3] Shih SR(2020)A report from the Brescia renal COVID task force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection Kidney Int 98 20-26

[4] Goicoechea M(2020)CKD is a key risk factor for COVID-19 mortality Nat Rev Nephrol 16 705-706

[5] Cámara LA(2020)Profiling early Humoral response to diagnose novel coronavirus disease (COVID-19) Clin Infect Dis 71 778-785

[6] Macías N(2020)Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World J Clin Med 9 3372-215

[7] de Morales AM(2020)SARS-CoV-2: the viral shedding vs infectivity dilemma. Infect dis health Infect Dis Health 25 210-356

[8] Rojas ÁG(2020)Prolonged virus shedding even after seroconversion in a patient with COVID-19 J Inf Secur 81 318-846

[9] Bascuñana A(2020)Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J.Infect. 81 816-441

[10] Alberici F(2020)IgG antibody response to SARS-CoV-2 infection and viral RNA persistence in patients on maintenance hemodialysis Am J Kidney Dis 76 440-1088

[1] Liu YC(2020)COVID-19: the first documented coronavirus pandemic in history Biom J 43 328-333

[2] Kuo RL(2020)COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain Kidney Int 98 27-34

[3] Shih SR(2020)A report from the Brescia renal COVID task force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection Kidney Int 98 20-26

[4] Goicoechea M(2020)CKD is a key risk factor for COVID-19 mortality Nat Rev Nephrol 16 705-706

[5] Cámara LA(2020)Profiling early Humoral response to diagnose novel coronavirus disease (COVID-19) Clin Infect Dis 71 778-785

[6] Macías N(2020)Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World J Clin Med 9 3372-215

[7] de Morales AM(2020)SARS-CoV-2: the viral shedding vs infectivity dilemma. Infect dis health Infect Dis Health 25 210-356

[8] Rojas ÁG(2020)Prolonged virus shedding even after seroconversion in a patient with COVID-19 J Inf Secur 81 318-846

[9] Bascuñana A(2020)Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J.Infect. 81 816-441

[10] Alberici F(2020)IgG antibody response to SARS-CoV-2 infection and viral RNA persistence in patients on maintenance hemodialysis Am J Kidney Dis 76 440-1088